Depreciation in USD of IO Biotech, Inc. from 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
IO Biotech, Inc. quarterly/annual Depreciation history and growth rate from 2021 to Q1 2025.
  • IO Biotech, Inc. Depreciation for the quarter ending March 31, 2025 was $61K, a 1.61% decline year-over-year.
  • IO Biotech, Inc. annual Depreciation for 2024 was $253K, a 17.7% increase from 2023.
  • IO Biotech, Inc. annual Depreciation for 2023 was $215K, a 107% increase from 2022.
  • IO Biotech, Inc. annual Depreciation for 2022 was $104K, a 5100% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

IO Biotech, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $61K -$1K -1.61% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2024 $62K +$15K +31.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2023 $47K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14

IO Biotech, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $253K +$38K +17.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $215K +$111K +107% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $104K +$102K +5100% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $2K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.